Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

Europe’s minimal residual disease (MRD) testing market has witnessed remarkable growth, underscoring its pivotal role in healthcare diagnostics. Valued at $265.6 million in 2021, this market is poised ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...

This study presents important findings on the role of CXXC-finger protein 1 in regulatory T cell gene regulation and function ... Factor Staining Buffer Set (00-5523-00; Invitrogen). Flow cytometry ...

"This discovery is an important step toward using natural biological tools to improve cancer treatment," says Hanayama, lead author of the study. "By using extracellular vesicles, we can enhance ...

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

T. Rowe Price is undervalued, trading at ~10x earnings with a 5.3% dividend yield, and poised for flow stabilization and earnings growth. Management aims for flat to positive flows in 2025 ...